Article
Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era.
The Netherlands journal of medicine - 1 Oct 2014
Berden F A C, Kievit W, Baak L C, Bakker C M, Beuers U, Boucher C A B, Brouwer J T, Burger D M, van Erpecum K J L, van Hoek B, Hoepelman A I M, Honkoop P, Kerbert-Dreteler M J, de Knegt R J, Koek G H, van Nieuwkerk C M J, van Soest H, Tan A C I T L, Vrolijk J M, Drenth J P H
Abstract excerpt
BACKGROUND: A new era for the treatment of chronic hepatitis C is about to transpire. With the introduction of the first-generation protease inhibitors the efficacy of hepatitis C treatment improved significantly. Since then, the therapeutic agenda has moved further forward with the recent approval of sofosbuvir and the expected approval of agents such as simeprevir and daclatasvir. This paper, developed parallel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.